Retraction: Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan (Japanese Journal of Clinical Oncology (hyv185) DOI: 10.1093/jjco/hyv185);Forkhead box protein k1 recruits TET1 to act as a tumor suppressor and is associated with MRI detection

Japanese Journal of Clinical Oncology

Volumn 46, Issue 3, 2016, Pages 209-221

  Sun, Taotao ^a   Wang, Huijuan ^b   Li, Qiang ^c   Qian, Zhaoxia ^a   Shen, Caijie ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

^c Ningbo NO7 Hospital   (China)

Author keywords

Foxk1; TET1; Tumor suppressor; Twist; VEGF

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; GLUTATHIONE TRANSFERASE; NERVE CELL ADHESION MOLECULE; REGULATOR PROTEIN; TEN ELEVEN TRANSLOCATION 1; TRANSCRIPTION FACTOR FOXK1; TRANSCRIPTION FACTOR FOXK2; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN; CADHERIN; DNA BINDING PROTEIN; FOXK1 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; TET1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; TWIST1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FOXK1 GENE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; OVERALL SURVIVAL; PREDICTIVE VALUE; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECURRENCE FREE SURVIVAL; RNA SEQUENCE; SURVIVAL PREDICTION; UPREGULATION; BREAST TUMOR; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR RECURRENCE;

BREAST NEOPLASMS; CADHERINS; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS; TWIST TRANSCRIPTION FACTOR; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84960361741     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyab148     Document Type: Erratum

References (17)

1. Shi X, Seldin DC, Garry DJ. Foxk1 recruits the Sds3 complex and represses gene expression in myogenic progenitors. Biochem J 2012;446:349-57.
2. Shi X, Garry DJ. Sin3 interacts with Foxk1 and regulates myogenic progenitors. Mol Cell Biochem 2012;366:251-8.
3. Bowman CJ, Ayer DE, Dynlacht BD. Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs. Nat Cell Biol 2014;16:1202-14.
4. Cimmino L, Dawlaty MM, Ndiaye-LobryD, et al. TET1 is a tumor suppressor of hematopoietic malignancy. Nat Immunol 2015;16:653.
5. Neri F, Dettori D, Incarnato D, et al. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway. Oncogene 2015;34:4168-76.
6. Lu HG, Zhan W, Yan L, et al. TET1 partially mediates HDAC inhibitorinduced suppression of breast cancer invasion. Mol Med Rep 2014;10:2595-600.
7. De Santis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014;64:52-62.
8. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011;331:1559-64.
9. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
10. Bai F, Chan HL, Scott A, et al. BRCA1 suppresses epithelial-tomesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Res 2014;74:6161-72.
11. Yu J, Xie F, Bao X, Chen W, Xu Q. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. Mol Cancer 2014;13:121.
12. Varinska L, Gal P, Mojzisova G, Mirossay L, Mojzis J. Soy and Breast Cancer: Focus on Angiogenesis. Int J Mol Sci 2015;16:11728-49.
13. Ferrara N. Binding to the extracellular matrix and proteolytic processing:two key mechanisms regulating vascular endothelial growth factor action. Mol Biol Cell 2010;21:687-90.
14. Li S, Wei Q, Li Q, Zhang B, Xiao Q. Down-regulating HIF-1alpha by lentivirus-mediated shRNA for therapy of triple negative breast cancer. Cancer Biol Ther 2015;16:866-75.
15. Guru SK, Pathania AS, Kumar S, et al. Secalonic acid-D represses HIF-1alpha/VEGF mediated angiogenesis by regulating the Akt/mTOR/ p70S6 K signaling cascade. Cancer Res 2015;15:2886-96.
16. Pathak AP, McNutt S, Shah T, Wildes F, Raman V, Bhujwalla ZM. In vivo 'MRI phenotyping' reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis. PLoS One 2013;8:e63146.
17. Mustafi D, Zamora M, FanXB, et al. MRI accurately identifies early murine mammary cancers and reliably differentiates between in situ and invasive cancer: correlation of MRI with histology. NMR Biomed 2015;28:1078-86.